These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 9139802)
21. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Sun J; Meyers MJ; Fink BE; Rajendran R; Katzenellenbogen JA; Katzenellenbogen BS Endocrinology; 1999 Feb; 140(2):800-4. PubMed ID: 9927308 [TBL] [Abstract][Full Text] [Related]
22. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066 [TBL] [Abstract][Full Text] [Related]
23. Helix 12 in the human estrogen receptor (hER) is essential for the hER function by overcoming nucleosome repression in yeast. Gu X J Cell Biochem; 2002; 86(2):224-38. PubMed ID: 12111992 [TBL] [Abstract][Full Text] [Related]
24. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784 [TBL] [Abstract][Full Text] [Related]
25. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465 [TBL] [Abstract][Full Text] [Related]
27. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965 [TBL] [Abstract][Full Text] [Related]
28. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells. Wooge CH; Nilsson GM; Heierson A; McDonnell DP; Katzenellenbogen BS Mol Endocrinol; 1992 Jun; 6(6):861-9. PubMed ID: 1495491 [TBL] [Abstract][Full Text] [Related]
29. N-terminal activation function is dominant in ligand-dependent transactivation of medaka estrogen receptor alpha in human cells. Mezaki Y; Yoshida T; Yanagisawa J; Kato S Biochem Biophys Res Commun; 2001 Dec; 289(3):763-8. PubMed ID: 11726214 [TBL] [Abstract][Full Text] [Related]
30. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507 [TBL] [Abstract][Full Text] [Related]
31. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators. Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811 [TBL] [Abstract][Full Text] [Related]
32. Both N- and C-terminal transactivation functions of DNA-bound ERalpha are blocked by a novel synthetic estrogen ligand. Yamamoto Y; Wada O; Takada I; Yogiashi Y; Shibata J; Yanagisawa J; Kitazato K; Kato S Biochem Biophys Res Commun; 2003 Dec; 312(3):656-62. PubMed ID: 14680815 [TBL] [Abstract][Full Text] [Related]
33. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer. Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982 [TBL] [Abstract][Full Text] [Related]
34. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Jeyakumar M; Tanen MR; Bagchi MK Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239 [TBL] [Abstract][Full Text] [Related]
35. Temperature dependence of estrogen binding: importance of a subzone in the ligand binding domain of a novel piscine estrogen receptor. Tan NS; Frecer V; Lam TJ; Ding JL Biochim Biophys Acta; 1999 Nov; 1452(2):103-20. PubMed ID: 10559464 [TBL] [Abstract][Full Text] [Related]
36. Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin. Itoh T; Saura Y; Tsuda Y; Yamada H Chirality; 1997; 9(7):643-9. PubMed ID: 9366025 [TBL] [Abstract][Full Text] [Related]
37. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204 [TBL] [Abstract][Full Text] [Related]
38. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells. Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249 [TBL] [Abstract][Full Text] [Related]